Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate

    • Product Name N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate
    • Alias HATU
    • Einecs 282-817-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    381829

    Product Name N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate
    Synonym HBTU
    Cas Number 94790-37-1
    Molecular Formula C11H16F6N3O3P
    Molecular Weight 379.23
    Appearance white to off-white crystalline powder
    Solubility soluble in DMF, DMSO, and acetonitrile
    Storage Temperature 2-8°C
    Purity ≥98%
    Application peptide coupling reagent
    Melting Point 158-162°C
    Sensitivity moisture sensitive

    As an accredited N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, screw-cap vial containing 1 gram of N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate, labeled with hazard symbols and product details.
    Shipping Shipping **N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate** requires careful handling. The chemical should be transported in tightly sealed, inert containers, protected from moisture and light. It must be shipped as a hazardous material, compliant with relevant regulations (such as IATA or DOT). Appropriate labeling and documentation are essential to ensure safety during transit.
    Storage Store N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate in a cool, dry, well-ventilated area, away from heat, moisture, and incompatible substances such as strong acids or bases. Keep the container tightly closed and protected from light. Store under inert atmosphere if possible, and avoid prolonged exposure to air. Follow all relevant safety guidelines and consult the material safety data sheet (MSDS) for details.
    Application of N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate

    Applications of N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate in Industrial Manufacturing

    N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate (commonly known as HATU) plays a critical role as a coupling reagent in multiple sectors, most notably pharmaceutical synthesis, peptide manufacturing, oligonucleotide production, specialty chemical research, and diagnostic kit preparation. Below we outline key application scenarios, specifying industry regulations, actual inclusion ratios, manufacturing integration points, and resulting end products manufactured by our clients worldwide.

    1. Peptide Synthesis for Pharmaceutical Intermediates

    Major peptide contract manufacturers and innovative biotech firms rely on this coupling agent for amide bond formation in solid-phase peptide synthesis, where high purity and minimal epimerization are strictly required. Customers integrate our reagent directly in the peptide elongation step, optimizing reaction time and sequence fidelity for complex therapeutic peptides and building blocks entering preclinical or commercial pipelines.

    Industry compliance standards

    • Current Good Manufacturing Practice (cGMP, 21 CFR parts 210 & 211)
    • European Pharmacopoeia (Ph. Eur.), especially for injectable peptide APIs
    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • US FDA QSR for pharmaceutical manufacturing equipment and consumables

    Typical usage ratio

    • 0.9–1.2 equivalent per amino acid coupling; precise dosage depends on resin loading and coupling sequence; excess may be used for difficult residues

    Downstream process integration

    • Added at the amino acid coupling step on automated or manual solid-phase peptide synthesis (SPPS) reactors
    • Combined with bases such as DIPEA immediately before use to ensure maximum reactivity and avoid hydrolysis
    • Used throughout iterative deprotection-coupling cycles until full peptide assembly

    Final product types

    • Pharmaceutical-grade linear, cyclic, or stapled peptides in bulk or lyophilized form
    • Active Pharmaceutical Ingredients (APIs) based on peptide backbones
    • Research peptides for structure-activity relationship (SAR) studies
    • Custom synthetic peptides for diagnostic or vaccine applications

    2. Oligonucleotide Conjugation in Diagnostic Reagent Manufacturing

    Specialty diagnostic reagent producers employ this uronium-based coupling agent in the construction of oligonucleotide-protein or oligonucleotide-small molecule conjugates, where reliable activation and minimal side-product formation enable sensitive detection platforms and molecular diagnostics.

    Industry compliance standards

    • ISO 13485:2016 for In Vitro Diagnostic Medical Devices
    • CLSI guidelines (Clinical Laboratory Standards Institute) for kit validation
    • EU In Vitro Diagnostic Regulation (IVDR 2017/746)
    • US FDA 21 CFR Part 820 for quality systems in diagnostic manufacturing

    Typical usage ratio

    • 0.8–1.5 molar equivalents relative to oligonucleotide terminal group; ratio refined based on desired conjugation efficiency and steric accessibility

    Downstream process integration

    • Applied in post-synthetic conjugation protocols, often after the primary oligonucleotide synthesis and purification
    • Activated oligonucleotide intermediates are transferred to reaction vessels equipped for protein or hapten conjugation, controlling temperature and pH to maximize selectivity
    • Integration typically takes place in batch production with inline HPLC or mass spec QC

    Final product types

    • Hybrid oligonucleotide-protein conjugates for immunoassay signal amplification
    • Labeled DNA or RNA probes for PCR and qPCR assays
    • Custom molecular beacon probes with unique fluorescent or biotin tags
    • Oligos for DNA microarray and flow cytometry reagents

    3. API Intermediate Formation in Small Molecule Drug Synthesis

    API manufacturers, particularly those developing peptide-mimetic and macrocyclic drugs, use this coupling reagent during late-stage intermediate synthesis, where direct amide and ester bond formation is essential for accessing patent-protected molecular scaffolds. This allows production of advanced intermediates with high yield and significant impurity control according to regulatory expectations for clinical trial and commercial supply.

    Industry compliance standards

    • ICH Q11: Development and Manufacture of Drug Substances
    • US FDA DMF guidance for Type II Drug Master Files
    • Chinese Pharmacopoeia for local market registration
    • Japanese PMDA requirements for intermediates in pharmaceutical processes

    Typical usage ratio

    • 1.0–1.3 equivalents based on carboxylic acid or amine content, with adjustments based on solubility in solvents such as DMF, DCM, or NMP

    Downstream process integration

    • Dosed directly into the solution-phase synthesis reactor during condensation or cyclization of complex intermediates
    • Works in conjunction with auxiliary bases and scavengers; often used at mid- to final-stage synthesis when starting material value justifies higher coupling efficiency
    • Process temperatures and reaction sequence optimized for each target structure

    Final product types

    • Small molecule API intermediates for antiviral, anticancer, or CNS-active agents
    • Macrocyclic intermediates for targeted therapies
    • Advanced intermediates for peptide-linked drug conjugates
    • Prodrug precursors for new chemical entity (NCE) pipelines

    4. Preparation of Site-Specific Conjugates in Antibody-Drug Conjugate (ADC) Manufacturing

    Leading contract development and manufacturing organizations (CDMOs) specializing in ADCs apply this coupling agent for the reliable activation of payload linkers, enabling highly controlled, site-specific antibody conjugation crucial for therapeutic index optimization and regulatory compliance in biopharmaceuticals.

    Industry compliance standards

    • ICH Q5E: Comparability of Biotechnological/Biological Products
    • US FDA Guidance for Industry: Antibody-Drug Conjugates
    • European Medicines Agency (EMA) Guidance on ADCs
    • Sterile manufacturing protocols per USP <797> and <800>

    Typical usage ratio

    • 1.0 equivalent per linker functional group; the ratio can be reduced for homogeneous conjugation or increased when dealing with sterically hindered antibody sites

    Downstream process integration

    • Activated at the payload-linker assembly phase, typically following linker synthesis and prior to conjugation with the antibody molecule
    • Employs controlled temperature, time, and ratio settings in aseptic suites for consistency
    • Process monitored using real-time analytics (SEC, LC-MS) for aggregation and conjugation efficiency

    Final product types

    • ADC intermediates with cleavable and non-cleavable linkers
    • Site-specific conjugated monoclonal antibodies
    • Payload-linker constructs for combination therapies
    • Preclinical ADC candidates and clinical batch materials

    5. Synthesis of Functionalized Polymers for Life Science Research Tools

    Manufacturers of advanced polymer supports and affinity resins for chromatography and proteomics utilize this coupling reagent in the functionalization of resin beads, synthetic carriers, and microparticles, where precise ligand attachment density and chemical uniformity are required for downstream separation or enrichment workflows in life science labs.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems for manufacturing and QC
    • REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) compliance for polymer handling in Europe
    • RoHS restrictions for products sold in analytical instrumentation supply chains
    • Manufacturer-specific protocols for lot-release and functional group determination

    Typical usage ratio

    • 1.1–1.4 equivalents relative to resin functional group capacity; adjusted according to desired ligand loading and swelling characteristics

    Downstream process integration

    • Introduced during batch or continuous flow modification of pre-activated support matrices
    • Applied after initial polymer bead synthesis and swelling, enabling direct activation of carboxyl or amine pre-loaded surfaces
    • Final functionalization step monitored by titration or colorimetric assays to validate ligand density

    Final product types

    • Affinity chromatography resins for peptide or protein purification
    • Tagged magnetic microbeads for immunoprecipitation and cell sorting tools
    • Solid-phase extraction (SPE) cartridges tailored for analytic chemistry
    • Polymer supports for enzyme immobilization and biosensor applications
    Free Quote

    Competitive N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate: A Closer Look from the Manufacturer’s Bench

    Chemical Innovation on the Factory Floor

    Few modern peptide syntheses move ahead without tools that help researchers form bonds with reliability and speed. In our manufacturing plant, skilled teams have worked with N,N,N',N'-Tetramethyl-O-(N-Succinimidyl)Uronium Hexafluorophosphate—often known by chemists as TSTU Hexafluorophosphate or by the shorthand TSTU·PF6—for years. This product walked across our concrete floors as raw materials, moved through reactors under strict temperature watch, and left the building in heavy containers destined for labs that demand consistency every time. We have seen its impact on projects large and small, and each shipment bottles up long hours of precise process control and rigorous quality checks.

    Why this Coupling Reagent Gets the Call

    Peptide synthesis pushes reagents to perform at a high level. The pressure for short reaction times, high yields, and low levels of epimerization never lets up, especially as custom peptides grow in complexity and volume. Early on, research focused on carbodiimides for amide bond formation, but issues with racemization and by-product removal stayed persistent. When TSTU·PF6 showed up as a coupling agent, it brought several improvements. It presents as a white crystalline solid, easy to handle with protective gear and air management protocols. That’s appreciated by the team on the loading dock as much as by chemists at the SPME bench.

    Our experience taught us that TSTU·PF6 offers better solubility than the chloride version in polar organic solvents such as acetonitrile, DMF, and DMSO. This difference matters during gram-to-kilogram batch upscaling, where solvent choice, solubility, and residue removal can decide cost and turnaround time. It enters amide bond-forming reactions with speed, especially in the context of solid-phase protocols where time equals throughput. Time and again, real-world data lines up: yields trend higher, and racemization indexes drop compared to older uronium, carbodiimide, or phosphonium salts.

    What Sets TSTU·PF6 Apart in the Reagent Lineup

    In-house trials have run TSTU·PF6 against comparative coupling agents—HATU, HBTU, TBTU, DCC, DIC—to monitor both performance and ease of downstream processing. TSTU·PF6 generates lower quantities of hazardous urea and by-products than carbodiimides, improving workplace cleanliness and maintenance frequency for purification units. It exhibits a good shelf-life in well-sealed units, resisting hydrolysis so product losses remain within expected limits, even in climate-controlled warehouses over extended storage periods.

    We do not see the same stubborn reaction by-products as with HBTU, and our waste handling staff rarely express concern over difficult-to-manage residues. The hexafluorophosphate anion stands out, too. In a business driven by purity, the PF6- option sheds inorganic counterions that interfere less in downstream measurements and extractions. During lyophilization or final crystallization, this seems minor but grows more important as batch sizes climb. These small operational realities never make product flyers, but in our work, the difference builds up over fiscal quarters and keeps maintenance logs slimmer.

    Usage on the Factory and Research Scale

    Our operators portion TSTU·PF6 into reactors at temperatures safely below its decomposition point. Chemists watch for exotherms and sequence additions of bases like N-methylmorpholine or DIPEA. Once the activated N-hydroxysuccinimide ester intermediate emerges, nucleophilic attack from an amine substrate typically follows quickly. Precise metering prevents excess—tight yields come from process discipline, not shortcuts.

    Customers report success coupling simple amino acids or more elaborate peptide fragments, both in solution-phase and solid-phase routes. The smoothness of this chemistry comes from the uronium backbone. Instead of cycling through older coupling agents that boost racemization or clog resin beds, most industrial peptide syntheses stick with reagents that consistently deliver clean transformations. Consistency comes from years grinding out process details and refining batch analytics rather than marketing blurbs.

    Specifications That Matter to Chemists and Engineers

    TSTU·PF6 ships from our plant as a crystalline substance, white to off-white in color when all upstream purification hits spec. Each production release triggers a careful workup on NMR, HPLC, and moisture content to ensure nothing falls through the cracks. Few things kill a run faster than out-of-specification water levels or low purity.

    Standard packaging includes sealed drums or safety bottles that ride the line between lab convenience and industrial supply chain efficiency. Engineers sign off on every lot after confirming stability across normal transport and storage conditions. As a technical team, we watch out for thermal decomposition and control oxygen and humidity in every stage of packaging. No one wants to field late-night calls about lost product or shipments that never cleared customs due to sloppy spec control—consistent track records build trust both inside the plant and out.

    Broader Differences from Other Uronium Products

    No two coupling agents work the same way across all settings. TSTU·PF6 sidesteps the pitfalls often seen with its chloride cousin. The hexafluorophosphate offers less risk of introducing chloride contamination, which matters for scale-up and for end-users chasing analytical resolution of charged species. In situations where the product purity or downstream performance rely on tight control of counterions, this detail becomes mission critical.

    Compared to HATU or HBTU—which layer in bulky benzotriazole groups—TSTU·PF6 often gives cleaner mass spectra and requires fewer steps in extraction workups. That doesn’t mean every application favors it, but on the lines that require dependable amide formation, few approaches have shown the same plug-and-play performance. The difference shows up not just in test tubes, but when monitoring scale-up batches running for hours or days—pumps keep cycling, no buildups form, and final product isolation reminds our production team why tweaks to the uronium backbone matter more than literature reviews often suggest.

    Operational Realities in Manufacturing

    Delivering TSTU·PF6 in volume means managing solvent recovery, onsite air control, and regular reanalysis of stored product lots. Quality culture in the plant stresses transparency from raw input assessments through to product release. Every kilogram that leaves our facility embodies decisions made by technicians who understand tight batch control makes or breaks customer trust.

    Incidents in the past have pointed out the need for air-tight handling, especially during periods of high humidity. Production teams regularly inspect packaging for signs of moisture ingress, since the uronium center and hexafluorophosphate both dislike water. Decomposition losses cut into both our bottom line and our customers’ schedules if overlooked. Upstream audits focus on making sure that every drum shipped matches spec, whether headed for a local university or a multinational API producer.

    Supporting Facts and In-Process Statistics

    Lab QC teams spot-check each batch using proton and phosphorus NMR and crosscheck mass spec for expected fragmentation. Purity levels for every production batch consistently trend above 99 percent when upstream controls run smoothly. Moisture content readings stay below 0.5 percent in nearly every lot. In our records, shelf life at 20°C in sealed containers lines up with data from both internal and external validation studies performed under ICH conditions. Thermal gravimetric analysis, performed by our analytical scientists, provides peace of mind to downstream workflow planners.

    Our plant teams have even run stability challenges by seeding samples in uncontrolled environments, documenting decomposition trends, and feeding insights back into process adjustments. Our homegrown QC software records the journey of every kilogram, flagging any outlier that drifts even slightly from accepted benchmarks. Many operators trust these logs when preparing charges for high-value customers in biopharma and academic settings, where lost material can push budgets off course or cut time from tight project windows.

    Waste Management and Sustainability Pressures

    All coupling agents bring with them a burden of waste. The environmental team audits procedures for spent uronium, succinimide by-products, and PF6 residues. TSTU·PF6 edges out older agents by producing a more straightforward waste stream—fewer persistent organic pollutants crop up compared to certain benzotriazole or phosphonium derivatives. Our departmental meetings have put a renewed focus on recycling solvent residues and capturing volatile organics, not to tick boxes, but to keep our site license and community standing.

    We track not only immediate by-products, but also longer-term impacts of hexafluorophosphate in site effluent. Researchers debate possible alternatives, but as of the last compliance audit, we outperform previous generations of reagents on measurable sustainability targets. Making those numbers possible requires design of in-process capture systems and monthly reviews with plant engineers and external stakeholders.

    Real-World Feedback from Production and End Users

    Customers tell us the main payoff comes from higher purities out the gate and less cleaning in their downstream lines. Few complaints land in our inbox about solubility or process fit, whether the user dissolves the product in DMF, DMSO, or acetonitrile. Troubleshooting requests almost always trace back to environmental factors, not flaws in the base chemistry.

    Our sales engineers regularly visit customer sites, trading notes with operators who run automated peptide synthesizers. Most report cuts in downtime and higher batch-to-batch reproducibility, and we routinely see repeat orders cluster around the same research programs, especially those pushing boundaries in peptide length or incorporating tricky unnatural amino acids.

    Meeting Regulatory and Safety Demands

    Plant safety managers reinforce handling standards every shift. They insist on fume hood usage and double-bagging protocols both to protect staff and to cut the rare but possible risk of allergies. Proper disposal of spent coupling mixtures stays top of mind, especially for staff cycling between uronium and carbodiimide lines. When new regulatory rules hit, teams adjust SOPs, retrain, and document every change to keep finished goods out of quarantine.

    New projects get scoped with direct input from process chemists who’ve seen reactors foam, filters clog, or solvent lines degrade from incompatible by-products in the past. Rather than rest on legacy protocols, we build out new process trains and pilot batch documentation to keep every lot tracked from cradle to shipment.

    Looking Toward New Applications and Process Solutions

    The drive for higher automation in peptide manufacturing feeds innovation on our floor as well. Customers working on conjugates, biologics, or diagnostic peptides push TSTU·PF6 into non-traditional coupling scenarios. These experiments feed back into our process groups who explore tweaks to reaction setup, order of additions, or solvent systems to match advances in synthesizer hardware.

    Process engineers challenge suppliers to hit tighter purity limits and scale gracefully without surprise side reactions or product drift. To support these efforts, manufacturing groups deploy more inline analytical tools—NIR, online HPLC, even real-time reaction calorimetry—to make sure every batch lives up to the specs internal chemists and external customers expect.

    Spotlighting the Importance of Traceability and Real-World QA

    As market demands accelerate timelines, especially for custom peptide applications, traceability takes on more weight. Operations teams document every step of production for each lot of TSTU·PF6, integrating batch records with digital QA systems. Plant staff see firsthand how tight traceability builds customer confidence, especially for pharmaceutical and biotechnological applications where every gram counts and recalls sting both reputation and bottom line.

    Our maintenance crews and quality personnel meet ever higher expectations for in-process and post-shipment support. On-the-ground know-how, not just paper quality certifications, closes the loop between production and application. This builds resilience during supply spikes, tighter regulatory blocks, or unexpected equipment downtime.

    Collaborating for Continuous Improvement

    No plant wins by standing still. New rounds of internal audits and external feedback keep TSTU·PF6 supply lines moving forward, not coasting on past results. Process chemists trade insights with academic groups, helping tweak coupling reagents for emerging fields like peptide–drug conjugates or oligonucleotide hybrid materials.

    Continuous improvement means picking up on weak spots, whether they come from feedstock changes, cleaning trends, or customers scaling up unexpectedly. Data from every batch, feedback from every user, and follow-up from every regulatory inspection combine to push adjustments. Sometimes this takes the shape of a minor process change; at times it calls for a plant-wide effort to retrain or restock.

    Final Thoughts from the Manufacturing Line

    Every package of TSTU·PF6 we ship leaves with the fingerprints of teams who live with the realities of large-scale chemistry. The product stands apart for its reliability, ease of use, and fewer headaches both at the bench and across global production lines. We draw value from hands-on experience, not just spec sheets or conference posters, and work hard to keep quality high, help customers succeed, and push chemical manufacturing towards safer, more sustainable outcomes.